IP Verse

Gillard, Richard Edward competitive analysis

Latest oppositions filed by Gillard, Richard Edward

Explore patent oppositions filed by Gillard, Richard Edward against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
EP3395339
Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 16, 2020
EP3395340
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 16, 2020
EP1633766
Modified Fluorinated Nucleoside AnaloguesGILEAD PHARMASSETDec 5, 2019
EP2981271
Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMAug 14, 2019
EP3004388
Detection And Quantification Of Donor Cell-Free Dna In The Circulation Of Organ Transplant RecipientsCHRONIX BIOMEDICALJul 31, 2019
EP2709613
Methods For Treating HcvGILEAD PHARMASSETAug 22, 2018
EP2822777
Multi-Layer Printing ProcessAMCOR GROUPJul 11, 2018
EP2604620
Modified Fluorinated Nucleoside AnaloguesGILEAD PHARMASSETMar 29, 2017
EP2730279
Immediate Release Formulations Of CinacalcetKHS PHARMA HOLDINGApr 22, 2016
EP2470529
A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivative For Pharmaceutical Use, And The Use Of A 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol Derivate With Substantially Undefined Crystal Shape For Preparing Said 1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol DerivativeMEDICHEM S.A.Feb 18, 2015

Latest PTAB cases involving Gillard, Richard Edward

Discover the latest PTAB cases involving Gillard, Richard Edward, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Gillard, Richard Edward with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GILLARD, RICHARD EDWARD10 - - -
AMGEN14163811
BOEHRINGER INGELHEIM4524589
GILEAD PHARMASSET - 16 - 10